1,4-Disubstituted-1H-1,2,3-triazoles 1 can easily be distinguished from the isomeric 1,5-disubstituted-1H-1,2,3-triazoles 2 by simple one-dimensional C-13 NMR spectroscopy using gated decoupling. The C-5 signal of 1 appears at delta similar to 120 ppm, while the C-4 signal of 2 appears at delta similar to 133 ppm. Computational studies also predict the upfield shift of C-5 of 1 relative to C-4 in 2.
TRIAZOLE-CROSSLINKED AND THIOETHER-CROSSLINKED PEPTIDOMIMETIC MACROCYCLES
申请人:Aileron Therapeutics, Inc.
公开号:US20130210745A1
公开(公告)日:2013-08-15
Provided herein are peptidomimetic macrocycles and methods of using such macrocycles for the treatment of disease.
本文提供了肽类模拟大环化合物以及利用这些大环化合物治疗疾病的方法。
[EN] TRIAZOLE-CROSSLINKED AND THIOETHER-CROSSLINKED PEPTIDOMIMETIC MACROCYCLES<br/>[FR] MACROCYCLES PEPTIDOMIMÉTIQUES RÉTICULÉS PAR TRIAZOLE ET PAR THIOÉTHER
申请人:AILERON THERAPEUTICS INC
公开号:WO2013123267A1
公开(公告)日:2013-08-22
Provided herein are peptidomimetic macrocycles and methods of using such macrocycles for the treatment of disease.
本文提供了肽类模拟大环和使用这种大环治疗疾病的方法。
TRIAZOLE MACROCYCLE SYSTEMS
申请人:Aileron Therapeutics, Inc.
公开号:US20160031936A1
公开(公告)日:2016-02-04
The present invention provides novel peptidomimetic macrocycles and methods for their preparation and use, as well as amino acid analogs and macrocycle-forming linkers, and kits useful in their production.
The present invention provides novel peptidomimetic macrocycles and methods for their preparation and use, as well as amino acid analogs and macrocycle-forming linkers, and kits useful in their production.
Therapeutic peptidomimetic macrocycles
申请人:Nash Huw M.
公开号:US20090275519A1
公开(公告)日:2009-11-05
The present invention provides biologically active peptidomimetic macrocycles for the treatment of cell proliferative disorders such as cancer and immunoproliferative disease.